2006
HIV prevalence, sociodemographic, and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia.
Shaboltas AV, Toussova OV, Hoffman IF, Heimer R, Verevochkin SV, Ryder RW, Khoshnood K, Perdue T, Masse BR, Kozlov AP. HIV prevalence, sociodemographic, and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2006, 41: 657-63. PMID: 16652041, DOI: 10.1097/01.qai.0000220166.56866.22.Peer-Reviewed Original ResearchConceptsInjection drug usersHigh-risk injection drug usersHIV prevalenceDrug usersActive injection drug usersBaseline HIV prevalenceHIV-1 prevalencePrevalent HIV infectionHIV-1 infectionHIV-positive individualsRecruitment methodsChain referralHIV infectionMedian ageHIV statusHIV-1Street outreachPrevalenceDemographic characteristicsPrevious monthRecruitment periodReferralInfectionBehavioral correlatesBehavioral variables
1994
A decline in HIV-infected needles returned to New Haven's needle exchange program: client shift or needle exchange?
Kaplan EH, Khoshnood K, Heimer R. A decline in HIV-infected needles returned to New Haven's needle exchange program: client shift or needle exchange? American Journal Of Public Health 1994, 84: 1991-4. PMID: 7998644, PMCID: PMC1615375, DOI: 10.2105/ajph.84.12.1991.Peer-Reviewed Original Research
1993
Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut
Heimer R, Kaplan E, Khoshnood K, Jariwala B, Cadman E. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. The American Journal Of Medicine 1993, 95: 214-220. PMID: 8356986, DOI: 10.1016/0002-9343(93)90263-o.Peer-Reviewed Original ResearchConceptsHIV-1 proviral DNANeedle exchange programsProviral DNANew Haven's needle exchange programNeedle exchangeHIV-1 prevalenceIntravenous drug usersNeedle exchange clientsDrug treatment programsPercentage of syringesDrug use habitsSyringe trackingDNA prevalenceNew HavenPolymerase chain reactionDrug treatmentDrug usersTreatment programPrevalenceChain reactionExchange programsSyringesMonthsProgram participantsFunded evaluation